4-fluorobenzyltrozamicol has been researched along with 4-diphenylacetoxy-1,1-dimethylpiperidinium in 1 studies
*4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups [MeSH]
*4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burbank, N; Calles-Escandon, J; Clark, PB; Elster, AW; Gage, HD; Garg, P; Garg, S; Kraas, J; Morton, K; Plaza, MJ; Wagner, JD | 1 |
1 other study(ies) available for 4-fluorobenzyltrozamicol and 4-diphenylacetoxy-1,1-dimethylpiperidinium
| Article | Year |
|---|---|
Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreas.
Topics: Animals; Fluorine Radioisotopes; Fluorobenzenes; Insulin-Secreting Cells; Mice; Pancreas; Parasympatholytics; Piperidines; Prediabetic State; Radiography; Tritium | 2009 |